{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T13:34:25Z","timestamp":1749735265302,"version":"3.37.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T00:00:00Z","timestamp":1712534400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Tuberculosis and Other Mycobacterial Diseases"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jctube.2024.100438","type":"journal-article","created":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T03:04:42Z","timestamp":1712631882000},"page":"100438","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Chest wall tumor following intravesical BCG instillation for non-muscle invasive bladder cancer"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1217-1555","authenticated-orcid":false,"given":"Marc","family":"Hartert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Deppe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludger","family":"Fink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jutta","family":"Kappes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jctube.2024.100438_b0005","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41585-021-00481-1","article-title":"100 years of Bacillus Calmette-Gu\u00e9rin immunotherapy: from cattle to COVID-19","volume":"18","author":"Lobo","year":"2021","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.jctube.2024.100438_b0010","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.jctube.2024.100438_b0015","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/MD.0000000000000119","article-title":"Bacillus Calmette-Gu\u00e9rin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature","volume":"93","author":"P\u00e9rez-Jacoiste As\u00edn","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jctube.2024.100438_b0020","doi-asserted-by":"crossref","first-page":"866","DOI":"10.6004\/jnccn.2022.0041","article-title":"NCCN Guidelines\u00ae Insights: Bladder Cancer, Version 2.2022","volume":"20","author":"Flaig","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.jctube.2024.100438_b0025","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41585-018-0055-4","article-title":"Mechanisms of BCG immunotherapy and its outlook for bladder cancer","volume":"15","author":"Pettenati","year":"2018","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.jctube.2024.100438_b0030","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/S1473-3099(21)00403-5","article-title":"100 years of Mycobacterium bovis bacille Calmette-Gu\u00e9rin","volume":"22","author":"Lange","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jctube.2024.100438_b0035","doi-asserted-by":"crossref","first-page":"6230409","DOI":"10.1155\/2019\/6230409","article-title":"Clinical spectrum of complications induced by intravesical immunotherapy of bacillus Calmette-Gu\u00e9rin for bladder cancer","volume":"2019","author":"Liu","year":"2019","journal-title":"J Oncol"},{"key":"10.1016\/j.jctube.2024.100438_b0040","article-title":"Evaluating the effectiveness of intravesical instillation of BCG by modified maintenance method in patients with high-risk Ta and T1 bladder cancer: a randomized clinical trial","volume":"17:11795549231184682","author":"Shakhssalim","year":"2023","journal-title":"Clin Med Insights Oncol"},{"key":"10.1016\/j.jctube.2024.100438_b0045","doi-asserted-by":"crossref","first-page":"6226","DOI":"10.3390\/jcm11206226","article-title":"Case report with systematic literature review on vascular complications of BCG intravesical therapy for bladder cancer","volume":"11","author":"King","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.jctube.2024.100438_b0050","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1148\/rg.2019180014","article-title":"Complications of intravesical BCG immunotherapy for bladder cancer","volume":"39","author":"Green","year":"2019","journal-title":"Radiographics"},{"key":"10.1016\/j.jctube.2024.100438_b0055","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.juro.2016.02.3005","article-title":"Immunotherapy for the treatment of urothelial carcinoma","volume":"197","author":"Donin","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.jctube.2024.100438_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110393","article-title":"Mechanisms of BCG in the treatment of bladder cancer-current understanding and the prospect","volume":"129","author":"Han","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jctube.2024.100438_b0065","doi-asserted-by":"crossref","first-page":"102142","DOI":"10.1016\/j.ctrv.2020.102142","article-title":"Recent advances in neoadjuvant immunotherapy for urothelial bladder cancer: what to expect in the near future","volume":"93","author":"Rey-C\u00e1rdenas","year":"2021","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.jctube.2024.100438_b0070","first-page":"136","article-title":"Two cases of subcutaneous tuberculous granuloma associated with BCG vaccination","volume":"45","author":"Kigawa","year":"2020","journal-title":"Tokai J Exp Clin Med"},{"key":"10.1016\/j.jctube.2024.100438_b0075","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1479-666X(06)80023-5","article-title":"Cutaneous mycobacterial infection post intravesical BCG installation","volume":"4","author":"Ng","year":"2006","journal-title":"Surgeon"},{"key":"10.1016\/j.jctube.2024.100438_b0080","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jaad.2005.07.041","article-title":"Cutaneous complications of intravesical treatments for bladder cancer: granulomatous inflammation of the penis following BCG therapy and penile gangrene following mitomycin therapy","volume":"55","author":"Kureshi","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jctube.2024.100438_b0085","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3109\/09546634.2010.500325","article-title":"Cutaneous complication after BCG vaccination: case report and review of the literature","volume":"22","author":"Keijsers","year":"2011","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jctube.2024.100438_b0090","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000430501","article-title":"Does the compliance to intravesical BCG differ between common clinical practice and international multicentric trials?","volume":"96","author":"Serretta","year":"2016","journal-title":"Urol Int"},{"key":"10.1016\/j.jctube.2024.100438_b0095","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1086\/344908","article-title":"Spectrum of bacille Calmette-Gu\u00e9rin (BCG) infection after intravesical BCG immunotherapy","volume":"36","author":"Gonzalez","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jctube.2024.100438_b0100","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/S0140-6736(22)01188-6","article-title":"Current best practice for bladder cancer: a narrative review of diagnostics and treatments","volume":"400","author":"Comp\u00e9rat","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jctube.2024.100438_b0105","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.eururo.2017.10.003","article-title":"Predicting response to intravesical bacillus calmette-gu\u00e9rin immunotherapy: are we there yet? A systematic review","volume":"73","author":"Kamat","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.jctube.2024.100438_b0110","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.juro.2017.12.057","article-title":"Purified protein derivative skin test prior to bacillus Calmette-Gu\u00e9rin therapy may have therapeutic impact in patients with nonmuscle invasive bladder cancer","volume":"199","author":"Niwa","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.jctube.2024.100438_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000477673","article-title":"Safety and efficacy of intravesical bacillus Calmette-Gu\u00e9rin immunotherapy in patients with non-muscle-invasive bladder cancer presenting with asymptomatic bacteriuria: a systematic review","volume":"99","author":"Poletajew","year":"2017","journal-title":"Urol Int"},{"key":"10.1016\/j.jctube.2024.100438_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2024.102478","article-title":"Xpert MTB\/RIF Ultra for the rapid diagnosis of extrapulmonary tuberculosis in a clinical setting of high tuberculosis prevalence country and interpretation of 'trace' results","volume":"145","author":"Nasrin","year":"2024","journal-title":"Tuberculosis"},{"key":"10.1016\/j.jctube.2024.100438_b0125","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3390\/vaccines11020387","article-title":"The interferon-gamma release assay versus the tuberculin skin test in the diagnosis of mycobacterium tuberculosis infection in BCG-vaccinated children and adolescents exposed or not exposed to contagious TB","volume":"11","author":"Druszczynska","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.jctube.2024.100438_b0130","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.3390\/cancers15071937","article-title":"Efficacy of different bacillus of Calmette-Gu\u00e9rin (BCG) strains on recurrence rates among intermediate\/high-risk non-muscle invasive bladder cancers (NMIBCs): single-arm study systematic review, cumulative and network meta-analysis","volume":"15","author":"Del Giudice","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jctube.2024.100438_b0135","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/j.euf.2022.06.002","article-title":"Effect of levofloxacin on the efficacy and adverse events in intravesical bacillus Calmette-Guerin treatment for bladder cancer: results of a randomized, prospective, multicenter study","volume":"8","author":"Numakura","year":"2022","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.jctube.2024.100438_b0140","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13019-022-01877-9","article-title":"Resection and reconstruction of huge tumors in the chest wall","volume":"17","author":"Dai","year":"2022","journal-title":"J Cardiothorac Surg"},{"key":"10.1016\/j.jctube.2024.100438_b0145","doi-asserted-by":"crossref","first-page":"48","DOI":"10.24908\/pocus.v8i1.15831","article-title":"Sonographic features of a tuberculous cold abscess: a case report and literature review","volume":"8","author":"Alzarrad","year":"2023","journal-title":"POCUS J"},{"key":"10.1016\/j.jctube.2024.100438_b0150","article-title":"Thoracoabdominal actinomycosis - Chameleon through kaleidoscope","volume":"31","author":"Hartert","year":"2020","journal-title":"Respir Med Case Rep"}],"container-title":["Journal of Clinical Tuberculosis and Other Mycobacterial Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405579424000251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405579424000251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T04:20:37Z","timestamp":1738729237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405579424000251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":30,"alternative-id":["S2405579424000251"],"URL":"https:\/\/doi.org\/10.1016\/j.jctube.2024.100438","relation":{},"ISSN":["2405-5794"],"issn-type":[{"type":"print","value":"2405-5794"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chest wall tumor following intravesical BCG instillation for non-muscle invasive bladder cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jctube.2024.100438","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100438"}}